Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs) ; volume:13 ; number:1 ; day:2 ; month:10 ; year:2023 ; pages:1-9 ; date:12.2023
Egyptian liver journal ; 13, Heft 1 (2.10.2023), 1-9, 12.2023
- Creator
-
Hassan, Waleed Attia
Kamel, Sherif I.
Mahmoud, Ibrahim Abdel Naby
Makhlouf, Nahed
Moubark, Mahmoud
Hassany, Sahar M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-023-00284-6
- URN
-
urn:nbn:de:101:1-2024020809134665484581
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hassan, Waleed Attia
- Kamel, Sherif I.
- Mahmoud, Ibrahim Abdel Naby
- Makhlouf, Nahed
- Moubark, Mahmoud
- Hassany, Sahar M.
- SpringerLink (Online service)
Other Objects (12)
HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Identification of host and virologic factors for HBV- and HCV-associated pathogenesis
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Identification of host and virologic factors for HBV- and HCV-associated pathogenesis
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Identification of host and virologic factors for HBV- and HCV-associated pathogenesis
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)